Videos / Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
Lipids Management in GP Demystified
Maintaining Muscles of Independence – Sarcopenia Screening & Management
Work Up of a Breast Lump in GP – Practical Tips and Traps
Managing Opioid Dependence in GP – An Update
expert
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health